|
| |
Issue No. 8 - July 2010 |
|
Page
|
Article Title
|
|
7-14 |
Cancer in Kuwait: Magnitude of the Problem |
| |
A. Elbasmi1,
A. Al-Asfour1, Y. Al-Nesf2 , A.
Al-Awadi1
1Kuwait Cancer Control Center, Ministry of
Health, State of Kuwait, 2Ministry of Health,
State of Kuwait |
| |
Cancer registry data
obtained from the Kuwait Cancer Registry at Kuwait Cancer
Control Center (KCCC) of Ministry of Health, State of
Kuwait. The data covers the years 1974 to 2007. Aim of this
study: was to estimate the magnitude of the cancer problem
in Kuwait over the period 1974-2007. Materials and methods:
Age-adjusted incidence rates (ASR) with standard error (er)
and 95% confidence intervals (95% CI) of age-standardized
rates were estimated. Statistical significance was assessed
by examining the standardized rate ratio (SRR). Results: It
was noted that by following the Cancer registry data there
was a trend of increase in adjusted rates among both males
and females. Looking into specific cancers it was noticed
that comparing the ASR of colorectal cancer among Kuwaiti
males, it increased by about 5 folds over the last 33 years
and ranked the 1st most frequent site on the years
2003-2007. Prostate cancer incidence increased by 3 folds
(14.5 cases /100,000 populations) and ranked the 4th most
frequent site among Kuwaiti males. The incidence of Non
Hodgkin’s Lymphoma (NHL) and leukemia had increased by 1.5
to 2 folds over the same time period. The rise of lung
cancer incidence declined to similar rates compared to that
observed in the early 70s and 80s. For Kuwaiti females
breast cancer had the highest incidence among Kuwaiti
population (15 cases /100,000 populations), it increased by
3 folds (50 cases /100,000 populations) over the last 33
years. The incidence of colorectal cancer increased by about
4 folds; (13 cases /100,000 populations). NHL and leukemia
increased by 2-2.5 folds over the same studied duration.
Meanwhile Thyroid cancer increased by one fold. Conclusion &
Recommendations: Some of the differences in cancer rates
over the last 33 years are likely to be attributable to the
variation in exposure to specific etiologic factors that are
caused by differences in lifestyle and habits, such as
dietary, physical activity and obesity. Further research
with a view to understanding these changes in cancer
incidence is warranted. The need for an interventional
prevention programs that vigorously involve, diet,
anti-smoking and physical activity among both sexes. |
|
15-19 |
Early Infections in the Stem Cell
Transplant Recipients at AIIMS, New Delhi: A prospective
study |
| |
G.M.
Bhat1, L. Kumar2, A. Sharma2,
V. Kuchupillai2
1Dept. of Medical Oncology, SKIMS, Soura,
Srinagar, India, 2Dept. of Medical Oncology IRCH,
AIIMS, New Delhi, India |
| |
The pattern of infections
in neutropenic patients including those undergoing stem cell
transplant in the west has changed but the same may not be
the case in the developing countries as brought out through
some earlier observations in some transplant centers in
India. The department of medical oncology IRCH, AIIMS has
been providing bone marrow transplant facility for over a
decade now. It is one of the few bone marrow transplant
units in northern India. A prospective study conducted on 70
consecutive bone marrow transplant subjects at this center
was carried out with this perspective in view. Objectives:
To determine the frequency and pattern of infections in
haemopoietic stem cell transplant (HSCT) recipients at this
center in India. Keywords: Bone marrow transplant, stem cell
transplant, neutropenic sepsis |
|
20-27 |
IMRT Implementation and
Patient Specific Dose Verification with Film and Ion Chamber
Array Detectors |
| |
S.
Sathiyan, M. Ravikumar, C. Varatharaj, S.S. Supe, S.L.
Keshava
Department of Radiation Physics, Kidwai Memorial Institute
of Oncology, Bangalore, India |
| |
Implementation of
Intensity Modulation Radiotherapy (IMRT) and patient dose
verification was carried out with film and I’mariXX using
linear accelerator with 120-leaf Millennium dynamic
multileaf collimator (dMLC). The basic mechanical and
electrical commissioning and quality assurance tests of
linear accelerator were carried out. The leaf position
accuracy and leaf position repeatability checks were
performed for static MLC positions. Picket fence test and
garden fence test were performed to check the stability of
the dMLC and the reproducibility of the gap between leaves.
The radiation checks were performed to verify the position
accuracy of MLCs in the collimator system. The dMLC
dosimetric checks like output stability, average leaf
transmission and dosimetric leaf separation were also
investigated. The variation of output with gravitation at
different gantry angles was found to be within 0.9 %. The
measured average leaf transmission for 6 MV was 1.6 % and
1.8% for 18 MV beam. The dosimetric leaf separation was
found to be 2.2 mm and 2.3 mm for 6 MV and 18 MV beams. In
order to check the consistency of the stability and the
precision of the dMLC, it is necessary to carryout regular
weekly and monthly checks. The dynalog files analysis for
Garden fence, leaf gap width and step wedge test patterns
carried out weekly were in good agreement. Pretreatment
verification was performed for 50 patients with ion chamber
and I’mariXX device. The variations of calculated absolute
dose for all treatment fields with the ion chamber
measurement were within the acceptable criterion. Treatment
Planning System (TPS) calculated dose distribution pattern
was comparable with the I’mariXX measured dose distribution
pattern. Out of 50 patients for which the comparison was
made, 36 patients were agreed with the gamma pixel match of
>95% and 14 patients were with the gamma pixel match of
90-95% with the criteria
of 3% delta dose (DD) and 3 mm distance-to-agreement (DTA).
Commissioning and quality assurance of dMLC for IMRT
application requires considerable time and effort. Many
dosimetric characteristics need to be assessed carefully
failing which the delivered dose will be significantly
different from the planned dose. In addition to the issues
discussed above we feel that individual MU check is
necessary before the treatment is delivered. Keywords: IMRT,
dMLC, Quality Assurance, I’mariXX, DTA, Delta dose |
|
28-34 |
Quantitative Tumor Volume
VS TNM Staging: The Impact on Prognosis in Head and Neck
Cancer |
| |
R. Hadi1,
S. Kumar2, M. Srivastava2, M.C. Pant2,
P.K. Srivastava2, N. Jamal2
1Department of Radiation Oncology, IRCS Cancer
Hospital, India; 2Department of Radiotherapy,
Chhatrapati Shahuji Maharaj Medical University, India |
| |
Objectives: To evaluate
the prognostic value of tumor volume (TV) by clinical method
(CM) and Computerized Tomography (CT) scan in head and neck
(H&N) cancer. Materials and Methods: Total 25 patients’
(pts) pretreatment tumor volume (PT TV) was assessed
clinically by cuboid volume method. Afterwards contrast
enhanced computerized tomography (CECT) images of the pts
were transferred to workstation by DICOM software. The
computerized tomography tumor volume (CT TV) was obtained on
Radworks 6.0, using mouse control cursor. After assessment,
the patients were given 3 cycles of neoadjuvant chemotherapy
followed by radiotherapy by conventional method on Co-60
Theratron 780 C. After 1 month of treatment, TV was again
measured. Statistical method: Statistical analysis was done
on MSTAT statistical analysis software. Two-tailed student t
test, chi square test and test for two proportions for
significance had been used. Results: Large variations in
tumor volume were found both in intra as well as inter
T-stages. As the tumor size increases with T stages, the
difference in measurement of TV by both methods decreases.
CT TV results pre as well as post-treatment were more
consistent than clinical method. Conclusion: The use of TV
as a prognostic factor by CT scan seems to be more useful
parameter than the CM. TV should be included in the TNM
(tumor, node, and metastasis) classification after setting
the strict guidelines for tumor delineation, to solve the
discrepancy of treatment outcome in the same clinical stage.
Keywords: Head and neck cancer, tumor volume, CT scan |
|
35-38 |
Angiomyofibroblastoma of
the vulva: Report of a rare distinct entity |
| |
R.
Arora, A.A. Abou-Bakr, M.S. Ahmad
Department of Pathology, Farwaniya Hospital, Kuwait |
| |
Angiomyofibroblastoma is a
rare benign mesenchymal tumor of lower female genital tract.
It has characteristic histomorphology and shows
myofibroblastic differentiation. Clinically it is imperative
to differentiate angiomyofibroblastoma from other
mesenchymal tumors of this region especially aggressive
angiomyxoma which is locally infiltrative and needs long
term followup. We report clinical, histological, and
immunohistochemical features of a case of
angiomyofibroblastoma and discuss relevant points regarding
histogenesis and biological behaviour. We stress the need to
recognize this tumor on clinicopathologic basis to avoid any
potential therapeutic implications. Keywords: Angiomyof
ibroblastoma, vulva, mesenchymal tumor |
|
39-43 |
One Patient, Two
lymphomas, Three primaries |
| |
A.W.
Eshra1, A. Al-Hendal1, M. Al Enzi1,
M. Al-Mishaan1, W. Abo Dief2
1Department of Surgery, 2Department of
Histopathology, Sabah Hospital, Kuwait |
| |
Concomitant adenocarcinoma
and non-Hodgkin’s lymphoma, both located in the intestinal
tract, are unusual. Collision tumors of the colon on the
other hand are extremely rare neoplasms. A case of true
collision tumor of a marginal zone lymphoma and a moderately
differentiated adenocarcinoma of the ascending colon
(hepatic flexure) is reported. Simultaneously, a third
primary is identified as follicular lymphoma involving the
terminal ileum. Correlation with clinical history, radiology
investigations, endoscopic findings and histological
examination of the resected specimen as well as the use of
ancillary techniques such as immunohistochemistry are the
most useful in making the correct diagnosis of a synchronous
three primaries involving the small bowel and colon.
Therefore, we present these three primary synchronous
neoplasms involving two different parts of the
gastrointestinal tract, with two of these three primaries
colliding at one organ. Keywords: Lymphoma, adenocarcinoma,
collision tumor, concomitant tumors, immunohistochemistry |
|
44-47 |
Upper gastrointestinal
tract bleeding caused by a gastrointestinal stromal tumor of
the stomach |
| |
A.
Al-Hendal1, A.J. Al-Sabbagh1, M.
Al-Mishaan1, W. Abo Dief2
1Department of Surgery, 2Department of
Pathology Sabah Hospital, Ministry of Health, Kuwait |
| |
We report a case of upper
gastrointestinal bleeding caused by a gastrointestinal
stromal tumor in a 50-year old man. The patient was having
melena for two months, and on admission he was
hemodynamically stable. Upper G.I endoscopy showed diffuse
gastritis and an extrinsic compressing mass in the upper
part of the stomach. CT scan of the abdomen showed exophytic
mass in the fundus of the stomach, with central necrosis.
The patient was submitted to operative management. There
were no features of dissemination but there was invasion of
the hilum of the spleen. Wide local resection and
splenectomy performed. Post operative course was complicated
by a bleeding from the anastomotic site that required
re-exploration and suturing of the bleeding vessel.
Histologic examination revealed that it was composed of
spindle-shaped cells with elongated nuclei. Post operatively
the patient received adjuvant treatment with Imatinib [Gleevec].
The patient has an uneventful follow-up period so far.
Keywords: Upper gastrointestinal bleeding, Gastrointestinal
stromal tumors (GIST, Spindle cells, Imatinib mesylate |
|
48-51 |
Avascular Necrosis of Bone
in Children with Leukemia: Experience of Pediatric
Hematology Unit in Kuwait |
| |
M.J.
Bourisly, Z. Al-Mazidi, H. Saleh, M. Bourhama, E. Al-Matter
NBK 1, Department of Pediatrics, Al-Sabah Hospital, Ministry
of Health, State of Kuwait |
| |
Avascular necrosis of the
bone (AVNB) is an uncommon serious complication of acute
leukemia. Between the years 1997-2007, seven children with
acute leukemia of different risk groups presented with
symptoms, signs and investigational evidence of avascular
necrosis of bone. They were all diagnosed during their
maintenance chemotherapy except one patient who had AVNB
post-transplant following hematological relapse. Six
patients had avascular necrosis of the hip (AVNH), and one
patient had avascular necrosis of the foot. Other
complications for steroids, such as hyperglycemia were
observed in some of the patients. The steroids were omitted
in almost all patients immediately. Two patients had
surgical intervention and the rest received conservative
management. Two patients recovered fully and the rest are
still under follow-up at orthopedic clinic pending further
management. Key words: Avascular necrosis of the bone,
avascular necrosis of the hip, leukemia, BMT, steroid
therapy |
|
52-54 |
Fibrous Hamartoma of
Infancy in an unusual location- A case report |
| |
L.
Agrawal, R. Bansal, J. Singh, S. Sharma
Pathology Department, Giansagar Medical College and
Hospital, Banur, Punjab, India |
| |
Fibrous hamartoma of
infancy is an uncommon fibroproliferative lesion that occurs
only in infancy and childhood. It predominantly affects
healthy boys and can be found in almost any subcutaneous
tissue. The tumor is most frequently found in the axilla,
followed by shoulder, inguinal area, and chest wall. This
tumor can cause much concern about malignancy because it is
firm and may be fixed to underlying tissues. Despite the
occasional local recurrence, the clinical course is benign
and the prognosis is excellent. Treatment is by local
excision. The diagnosis is made by the characteristic
histologic features. In order to avoid the misdiagnosis of
malignancy and unnecessary radical therapy, both surgeon and
pathologist must be familiar with this entity. We report a
case of fibrous hamartoma of infancy in a 4-year-old boy in
gluteal region. Keywords: Fibrous hamartoma of infancy,
myofibroblast, organoid |
|
55-58 |
Anaplastic Variant of
Clear Cell Sarcoma of the Kidney - A rare Case Report |
| |
M.
Kukreja1, M. Kamal2, V.K. Iyer1,
A.A.S.R. Mannan3, S. Agarwal4
1Department of Pathology, AIIMS, New Delhi,
INDIA; 2Government College Rohtak, India; 3Department
of Pathology, Al Jahra Hospital, Kuwait; 4Department
of Pediatric Surgery, AIIMS, New Delhi, India |
| |
Clear cell sarcoma (CCSK)
of the kidney is an uncommon but distinctive pediatric renal
tumor with a characteristic histological pattern and marked
propensity for bone metastasis. The rare anaplastic variant
constitutes about 3% of cases of CCSK and carries an
unfavorable prognosis, with increased tumor recurrence and
resistant to chemotherapy. This variant show high frequency
of p53 gene mutation and p53 over expression in comparison
to the usual CCSK. We present a case of anaplastic variant
of CCSK in an 10-year-old boy with both cytologic and
histologic features, highlighting the importance of
recognizing this rare entity. Keywords: Bone metastasis;
clear cell sarcoma of the kidney; Wilms tumor. |
|
59-66 |
Assessment of Metabolic
Response to Pre-operative Treatment of Rectal Cancer |
| |
S. Abu
Zallouf, M. El-Sherify, S. Fayaz
Radiation Oncology Department, Kuwait Cancer Control Center,
Al-Shuwaikh, Kuwait. |
| |
In the era of targeted
therapy and high precision radiotherapy for patients with
cancer, tailoring and individualization of treatment is
needed more and more. In part to avoid ineffective
administration of a toxic treatment to a patient that
unlikely to get any benefit of it. And also to decrease the
expenses of treatment and saving the drugs and resources to
patients that deserve. Many predictive factors and markers
are searched and well-known in many malignancies, but still
rectal cancer lacks such predictors. As the pre-operative
chemoradiotherapy is becoming the standard of care of
treating patients with locally advanced rectal carcinoma, a
predictive factor, or at least an early indicator, of
patient’s response to treatment is needed. First, it may
help to modulate the pre-operative treatment by employing
another chemotherapeutic or targeted agent e.g. oxaloplatin
or cetuximab instead of the standard fluorouracil compounds.
It may also help to avoid continuation of unnecessary
protracted course of radiotherapy for 5—6 weeks for a
patient who is unlikely to achieve a satisfactory response.
This will help to avoid the definite toxicity of pelvic
irradiation and avoid wasting time before going to surgery.
Here comes the role of imaging techniques in predicting the
metabolic response such as functional computerized
tomography (CT) and magnetic resonance imaging (MRI) or
positron-emission tomography (PET) scan. In this review we
will go through the principles, indications and benefits of
employing such techniques in the assessment of response to
pre-operative chemoradiotherapy of rectal cancer. Keywords:
Rectal cancer, chemoradiotherapy, metabolic response,
predictor |
|
67-74 |
Oncology Centre, Salmaniya
Medical Complex (SMC), Bahrain |
| |
Cancer is one of the major
health problems in the Kingdom of Bahrain. It is the third
leading cause of death, after cardiovascular and endocrine
diseases, accounting for 10.6% (1 out of 10) of annually
reported deaths. The department of Oncology (SMC) is a
specialized cancer care centre in the kingdom of Bahrain and
Middle East. Salmaniya Medical Complex is accredited by
Canadian Board. SMC has collaboration with Princess Margret
Hospital, Canada in cancer management. The centre was
founded in 1996 and it is managed by the Ministry of Health,
Kingdom of Bahrain. The Oncology department offers
comprehensive treatment options for cancer in the form of
Radiation Oncology, Medical Oncology, Surgical Oncology,
Hematology Oncology, Pediatric Oncology and Palliative Care.
SMC Oncology treats over 500 new cancer patients each year
from the Kingdom of Bahrain and neighboring countries. It is
equipped with state-of-the-art medical equipments and
services including 38 in-patient beds and 15 day care beds.
Currently, the Centre has 21 highly qualified Consultants,
25 Residents, 4 Physicists, 7 Radiation Therapists and 50
paramedical staff. |

|
|
|